Work

A phase II multicenter study of L-alanosine, a potent inhibitor of adenine biosynthesis, in patients with MTAP-deficient cancer

Year: 2008

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1007/s10637-008-9160-1

Authors: Hedy Lee Kindler, Howard A. Burris, Alan B. Sandler, Ira Anton Oliff

Institutions: University of Chicago, Sarah Cannon, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Illinois CancerCare

Language: English

Topic: Biochemical and Molecular Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1998628096

FWCI: 1.69

Cites: 28

Cited by: 80

Related to: 10